Results 191 to 200 of about 31,435 (210)

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

New England Journal of Medicine, 2009
Anita Giobbie-Hurder, Ian Smith, John F Forbes   +2 more
exaly  

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Lancet Oncology, The, 2018
Marco Colleoni, Per Karsson, Jacquie Chirgwin   +2 more
exaly  

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial

Lancet Oncology, The, 2010
David Azria, Pascal Fenoglietto
exaly  

Letrozole

Reactions Weekly, 2013
openaire   +2 more sources

Letrozole

Reactions Weekly, 2012
openaire   +1 more source

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet Oncology, The, 2019
Eleftherios P Mamounas, Hanna Bandos, Jong-Hyeon Jeong   +2 more
exaly  

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Lancet Oncology, The, 2011
Meredith M Regan, Scd, Patrick Neven, Anita Giobbie-Hurder   +2 more
exaly  

LETROZOLE CUTS BREAST CANCER RECURRENCES

Ca-A Cancer Journal for Clinicians, 2004
exaly  

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial

Lancet Oncology, The, 2008
Meredith M Regan, Scd, Eliane Mery, Magali Lacroix-Triki   +2 more
exaly  

Letrozole

Reactions Weekly, 2002
openaire   +1 more source